Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil; Programa Acadêmico de Tuberculose, Faculdade de Medicina da Universidade Federal do Rio de Janeiro (UFRJ), RJ, Brazil.
Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.
Int J Infect Dis. 2020 Sep;98:299-304. doi: 10.1016/j.ijid.2020.06.070. Epub 2020 Jun 26.
To evaluate the clinical characteristics, diagnostic approach, and treatment outcomes of tuberculosis (TB) in children living in a high-burden metropolitan area.
This was a retrospective study, based on a medical chart review, involving children under 15 years old treated for TB between 2007 and 2016, in four primary health units (PHU) and three reference centers (RC) in five cities of Rio de Janeiro metropolitan area. Factors associated with TB treatment setting, microbiological diagnosis, and treatment outcomes were evaluated.
A total of 544 children were enrolled; 71% were treated in PHU, 36% were under 5 years old, and 72% had pulmonary TB (PTB). The HIV prevalence was 10% (31/322). Fifty-three percent had at least one microbiological test for TB, 68% of them (196/287) had TB confirmed. Among 222 children with previous TB contact, information on LTBI was available for 78 (35%), and only 17% (13/78) were treated. Extrapulmonary TB (56% vs 32%), microbiologically confirmed TB (77% vs 60%), and HIV positivity (18.5% vs 4.0%) were significantly more frequent in RC. Treatment in RC (odds ratio (OR) 3.08, 95% confidence interval (CI) 1.74-5.44) and PTB (OR 2.47, 95% CI 1.34-4.56) were independently associated with a microbiological diagnosis of TB. The treatment success rate was 85%. In the logistic regression analysis, HIV-infected children had a 2.5-fold higher risk of an unfavorable outcome (OR 2.53, 95% CI 1.0-6.38; p = 0.05).
Opportunities for TB prevention and early TB treatment are missed due to suboptimal close contact screening. Microbiological diagnosis of TB and drug susceptibility testing in children should be made available through more sensitive and accessible tests.
评估高负担大都市地区儿童结核病(TB)的临床特征、诊断方法和治疗结局。
这是一项回顾性研究,基于病历回顾,涉及 2007 年至 2016 年间在里约热内卢大都市区五个城市的四个初级保健单位(PHU)和三个参考中心(RC)接受结核病治疗的 15 岁以下儿童。评估了与 TB 治疗场所、微生物学诊断和治疗结局相关的因素。
共纳入 544 名儿童;71%在 PHU 治疗,36%年龄在 5 岁以下,72%患有肺结核(PTB)。HIV 流行率为 10%(31/322)。53%的儿童至少进行了一次结核病微生物学检测,其中 68%(287/422)的检测结果为结核病阳性。在 222 名有既往结核病接触史的儿童中,可获得潜伏性结核病感染(LTBI)信息的儿童有 78 名(35%),仅 17%(13/78)接受了治疗。RC 中,肺外结核病(56%比 32%)、微生物学确诊结核病(77%比 60%)和 HIV 阳性(18.5%比 4.0%)更为常见。RC 治疗(比值比(OR)3.08,95%置信区间(CI)1.74-5.44)和 PTB(OR 2.47,95%CI 1.34-4.56)与 TB 的微生物学诊断独立相关。治疗成功率为 85%。在逻辑回归分析中,HIV 感染儿童不良结局的风险增加 2.5 倍(OR 2.53,95%CI 1.0-6.38;p=0.05)。
由于未能充分进行密切接触筛查,错失了结核病预防和早期治疗的机会。应通过更敏感和易获得的检测方法,为儿童提供结核病的微生物学诊断和药敏检测。